Document is current
Any future updates will be listed below
-
Authors
Pun, Tsam Kiu https://orcid.org/0000-0002-7257-7867
Khoshnevis, Mona
Hosman, Tommy
Wilson, Guy H.
Kapitonava, Anastasia
Kamdar, Foram
Henderson, Jaimie M. https://orcid.org/0000-0002-3276-2267
Simeral, John D.
Vargas-Irwin, Carlos E. https://orcid.org/0000-0002-3526-3754
Harrison, Matthew T.
Hochberg, Leigh R. https://orcid.org/0000-0003-0261-2273
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (N2864C, A2295R, A2827R, A3803R)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (T32MH115895)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (UH2NS095548, U01NS098968)
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (U01DC017844, R01DC014034)
Croucher Foundation
Larry and Pamela Garlick, Wu Tsai Neurosciences Institute
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 26 August 2024
First Online: 21 October 2024
Competing interests
: The authors declare the following competing interests: The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or the Department of Veterans Affairs or the United States Government. The MGH Translational Research Center has a clinical research support agreement (CRSA) with Axoft, Neuralink, Neurobionics, Precision Neuro, Synchron, and Reach Neuro, for which L.R.H. provides consultative input. L.R.H. is a co-investigator on an NIH SBIR grant with Paradromics, and is a non-compensated member of the Board of Directors of a nonprofit assistive communication device technology foundation (Speak Your Mind Foundation). Mass General Brigham (MGB) is convening the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC); charitable gift agreements to MGB, including those received to date from Paradromics, Synchron, Precision Neuro, Neuralink, and Blackrock Neurotech, support the iBCI-CC, for which LRH provides effort. G.H.W. is a consultant for Artis Ventures. J.M.H. is a consultant for Neuralink and Paradromics and is a shareholder in Maplight Therapeutics and Enspire DBS. He is also an inventor of intellectual property licensed by Stanford University to Blackrock Neurotech and Neuralink.
